Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00

Industry

CPC
C07D515/00

This industry / category may be too specific. Please go to a parent level for more data

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,168,012
- Issue date Dec 17, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diaryl macrocyclic compound and pharmaceutical composition, and use...
- Patent number 12,129,258
- Issue date Oct 29, 2024
- PRIMEGENE (BEIJING) CO., LTD
- Li Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preparation method for ecteinascidin compound and intermediate thereof
- Patent number 12,122,784
- Issue date Oct 22, 2024
- Brightgene Bio-Medical Technology Co., Ltd.
- Jiandong Yuan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibit MCL-1 protein
- Patent number 12,091,425
- Issue date Sep 17, 2024
- Amgen Inc.
- David Karl Bedke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bridged tricyclic carbamoylpyridone compounds and uses thereof
- Patent number 12,054,496
- Issue date Aug 6, 2024
- Gilead Sciences, Inc.
- Hang Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hybrid cyclic libraries and screens thereof
- Patent number 12,049,521
- Issue date Jul 30, 2024
- The Johns Hopkins University
- Jun O. Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bridged tricyclic carbamoylpyridone compounds and uses thereof
- Patent number 12,024,528
- Issue date Jul 2, 2024
- Gilead Sciences, Inc.
- Hang Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic heteroaryl-substituted quinoline and azaquinoline compoun...
- Patent number 11,932,658
- Issue date Mar 19, 2024
- Bristol-Myers Squibb Company
- Xiaojun Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCL-2 inhibitors
- Patent number 11,903,950
- Issue date Feb 20, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of KEAP1-Nrf2 protein-protein interaction
- Patent number 11,897,900
- Issue date Feb 13, 2024
- JANSSEN PHARMACEUTICA NV
- J. Kent Barbay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,873,309
- Issue date Jan 16, 2024
- Incyte Corporation
- Kaijiong Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of Cystic Fibrosis Transmembrane Conductance regulator,...
- Patent number 11,866,450
- Issue date Jan 9, 2024
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antitumoral compounds
- Patent number 11,713,325
- Issue date Aug 1, 2023
- Pharma Mar, S.A.
- María del Carmen Cuevas Marchante
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic indoles as Mcl-1 inhibitors
- Patent number 11,691,989
- Issue date Jul 4, 2023
- Ascentage Pharma (Suzhou) Co., Ltd.
- Hao Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine derivative compound, pharmaceutically acceptable salt th...
- Patent number 11,535,627
- Issue date Dec 27, 2022
- Spark Biopharma, Inc.
- Seung Bum Park
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic inhibitors of Hepatitis B virus
- Patent number 11,504,382
- Issue date Nov 22, 2022
- Antios Therapeutics, Inc.
- Raffaele De Francesco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mcl-1 inhibitors and methods of use thereof
- Patent number 11,472,816
- Issue date Oct 18, 2022
- Astrazeneca AB
- Alexander Hird
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KEAP1-Nrf2 protein-protein interaction
- Patent number 11,427,601
- Issue date Aug 30, 2022
- JANSSEN PHARMACEUTICA NV
- J. Kent Barbay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antitumoral compounds
- Patent number 11,339,180
- Issue date May 24, 2022
- Pharma Mar, S.A.
- María del Carmen Cuevas Marchante
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Preparation for natural product trabectedin
- Patent number 11,339,179
- Issue date May 24, 2022
- CE Pharm Co., Ltd.
- Dawei Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antitumoral compounds
- Patent number 11,332,480
- Issue date May 17, 2022
- Pharma Mar, S.A.
- María del Carmen Cuevas Marchante
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyester resin, method for producing polyester resin, and toner us...
- Patent number 11,314,179
- Issue date Apr 26, 2022
- MITSUBISHI CHEMICAL CORPORATION
- Tadahiro Ozawa
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Grant
Compounds that inhibit MCL-1 protein
- Patent number 11,306,107
- Issue date Apr 19, 2022
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Receptors and spacers for a fluorescence-based lead ion chemosensor
- Patent number 11,193,891
- Issue date Dec 7, 2021
- Robert Bosch GmbH
- Mordechai Kornbluth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxygen linked pyrimidine derivatives
- Patent number 11,135,227
- Issue date Oct 5, 2021
- CTI Biopharma Corp.
- Stephanie Blanchard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemi...
- Patent number 11,130,769
- Issue date Sep 28, 2021
- Prelude Therapeutics, Incorporated
- Jincong Zhuo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bisaryl heterocycles as NRF2 activators
- Patent number 11,117,905
- Issue date Sep 14, 2021
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- James Francis Callahan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indazole derivatives useful as inhibitors of diacylglyceride O-acyl...
- Patent number 11,104,690
- Issue date Aug 31, 2021
- Merck Sharp & Dohme Corp.
- Dong-Ming Shen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bisaryl amides as NRF2 activators
- Patent number 11,078,216
- Issue date Aug 3, 2021
- GlaxoSmithKline Intellectual Property Development Limited
- James Francis Callahan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator,...
- Patent number 11,066,417
- Issue date Jul 20, 2021
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
AZAINDAZOLE MACROCYCLE COMPOUNDS AND USES THEREOF
- Publication number 20240383911
- Publication date Nov 21, 2024
- BroadenBio Co., Ltd.
- Gongping DUAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS
- Publication number 20240376084
- Publication date Nov 14, 2024
- HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
- Raffaella Dilucrezia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...
- Publication number 20240368189
- Publication date Nov 7, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SARM1 ENZYME ACTIVITY INHIBITOR AND APPLICATION THEREOF
- Publication number 20240368168
- Publication date Nov 7, 2024
- ARTIVILA BIOPHARMA
- Deqiang NIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Macrocyclic Compounds Having ENT1 Inhibiting Activity
- Publication number 20240368183
- Publication date Nov 7, 2024
- ITEOS BELGIUM S.A.
- Michael Deligny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CRYSTALLINE POLYMORPH OF LURBINECTEDIN AND IMPROVED PROCESS F...
- Publication number 20240352039
- Publication date Oct 24, 2024
- NATCO PHARMA LIMITED
- Srinivasa Chary CHINTALAPATI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL MACROCYCLIC AMINOPYRAZOLE COMPOUNDS AS CDK2 INHIBITORS
- Publication number 20240317777
- Publication date Sep 26, 2024
- Accutar Biotechnology Inc.
- Xiangzhu Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUN...
- Publication number 20240309019
- Publication date Sep 19, 2024
- Bristol-Myers Squibb Company
- XIAOJUN Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AS MODULATORS OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 (...
- Publication number 20240300976
- Publication date Sep 12, 2024
- GREY WOLF THERAPEUTICS LIMITED
- Martin QUIBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AN IMPROVED PROCESS FOR THE PREPARATION OF TRABECTEDIN
- Publication number 20240294549
- Publication date Sep 5, 2024
- NATCO PHARMA LIMITED
- Sunitha KOTHAMUNIREDDYGARI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF
- Publication number 20240262867
- Publication date Aug 8, 2024
- The Johns Hopkins University
- Jun O. Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OREXIN RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240254143
- Publication date Aug 1, 2024
- Jazz Pharmaceuticals Ireland Limited
- Prafulkumar CHOVATIA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC 1,3-BRIDGED 6-CHLORO-7-PYRAZOL-4-YL-1 H-INDOLE-2-CARBOX...
- Publication number 20240190893
- Publication date Jun 13, 2024
- Janssen Pharmaceutica N.V.
- Benoît Christian Albert Ghislain DE BOECK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCL-2 INHIBITORS
- Publication number 20240180924
- Publication date Jun 6, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTITUMORAL COMPOUNDS
- Publication number 20240166666
- Publication date May 23, 2024
- Pharma Mar, s.a.
- María del Carmen Cuevas Marchante
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20240166665
- Publication date May 23, 2024
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20240150377
- Publication date May 9, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DRUG ANTIBODY CONJUGATES
- Publication number 20240131180
- Publication date Apr 25, 2024
- Pharma Mar, s.a.
- Alfonso LATORRE LOZANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
- Publication number 20240132517
- Publication date Apr 25, 2024
- GOHARMONY THERAPEUTICS (SHENZHEN) CO., LTD.
- Liguang DAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NRF2-ACTIVATING COMPOUND
- Publication number 20240132519
- Publication date Apr 25, 2024
- SENJU PHARMACEUTICAL CO., LTD.
- Tomoyo MIYABE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF MYELOPEROXIDASE INHIBITORS
- Publication number 20240067651
- Publication date Feb 29, 2024
- BIOHAVEN THERAPEUTICS LTD.
- Gene M. DUBOWCHIK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20240018161
- Publication date Jan 18, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LYOPHILIZED PHARMACEUTICAL COMPOSITION AND USES OF A CRYSTALLIZED F...
- Publication number 20230416276
- Publication date Dec 28, 2023
- Pharma Mar, s.a.
- Maria Del Mar Zarzuelo Alba
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230416275
- Publication date Dec 28, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A LYOPHILIZED PHARMACEUTICAL COMPOSITION
- Publication number 20230399344
- Publication date Dec 14, 2023
- Pharma Mar, s.a.
- Maria Del Mar Zarzuelo Alba
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLIZED FORM OF LURBINECTEDIN AND METHOD OF MAKING THE SAME
- Publication number 20230399345
- Publication date Dec 14, 2023
- Pharma Mar, s.a.
- Maria Del Mar Zarzuelo Alba
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230382925
- Publication date Nov 30, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230382924
- Publication date Nov 30, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230374038
- Publication date Nov 23, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230365587
- Publication date Nov 16, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- C07 - ORGANIC CHEMISTRY

Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00

Industry

Parent Industries

Current Industry

Sub Industries

Patents Grantslast 30 patents

NLRP3 inflammasome inhibitors

Diaryl macrocyclic compound and pharmaceutical composition, and use...

Preparation method for ecteinascidin compound and intermediate thereof

Compounds that inhibit MCL-1 protein

Bridged tricyclic carbamoylpyridone compounds and uses thereof

Hybrid cyclic libraries and screens thereof

Bridged tricyclic carbamoylpyridone compounds and uses thereof

Tricyclic heteroaryl-substituted quinoline and azaquinoline compoun...

BCL-2 inhibitors

Inhibitors of KEAP1-Nrf2 protein-protein interaction

Heterocyclic compounds as immunomodulators

Modulators of Cystic Fibrosis Transmembrane Conductance regulator,...

Antitumoral compounds

Macrocyclic indoles as Mcl-1 inhibitors

Pyrimidine derivative compound, pharmaceutically acceptable salt th...

Tricyclic inhibitors of Hepatitis B virus

Mcl-1 inhibitors and methods of use thereof

Inhibitors of KEAP1-Nrf2 protein-protein interaction

Antitumoral compounds

Preparation for natural product trabectedin

Antitumoral compounds

Polyester resin, method for producing polyester resin, and toner us...

Compounds that inhibit MCL-1 protein

Receptors and spacers for a fluorescence-based lead ion chemosensor

Oxygen linked pyrimidine derivatives

Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemi...

Bisaryl heterocycles as NRF2 activators

Indazole derivatives useful as inhibitors of diacylglyceride O-acyl...

Bisaryl amides as NRF2 activators

Modulators of cystic fibrosis transmembrane conductance regulator,...

Patents Applicationslast 30 patents

AZAINDAZOLE MACROCYCLE COMPOUNDS AND USES THEREOF

INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...

SARM1 ENZYME ACTIVITY INHIBITOR AND APPLICATION THEREOF

Macrocyclic Compounds Having ENT1 Inhibiting Activity

NOVEL CRYSTALLINE POLYMORPH OF LURBINECTEDIN AND IMPROVED PROCESS F...

NOVEL MACROCYCLIC AMINOPYRAZOLE COMPOUNDS AS CDK2 INHIBITORS

TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUN...

COMPOUNDS AS MODULATORS OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 (...

AN IMPROVED PROCESS FOR THE PREPARATION OF TRABECTEDIN

HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF

OREXIN RECEPTOR AGONISTS AND USES THEREOF

MACROCYCLIC 1,3-BRIDGED 6-CHLORO-7-PYRAZOL-4-YL-1 H-INDOLE-2-CARBOX...

BCL-2 INHIBITORS

ANTITUMORAL COMPOUNDS

COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOF

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

DRUG ANTIBODY CONJUGATES

MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF

NRF2-ACTIVATING COMPOUND

PRODRUGS OF MYELOPEROXIDASE INHIBITORS

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

LYOPHILIZED PHARMACEUTICAL COMPOSITION AND USES OF A CRYSTALLIZED F...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

A LYOPHILIZED PHARMACEUTICAL COMPOSITION

CRYSTALLIZED FORM OF LURBINECTEDIN AND METHOD OF MAKING THE SAME

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR